Association study for 26 candidate loci in idiopathic pulmonary fibrosis patients from four European populations

Frontiers in Immunology

Volumn 7, Issue JUL, 2016, Pages

  Kishore, Amit ^a   Žižková, Veronika ^a   Kocourková, Lenka ^a   Petrkova, Jana ^a   Bouros, Evangelos ^b   Nunes, Hilario ^c   Loštáková, Vladimíra ^a   Müller Quernheim, Joachim ^d   Zissel, Gernot ^d   Kolek, Vitezslav ^a   Bouros, Demosthenes ^e   Valeyre, Dominique ^c   Petrek, Martin ^a  

^a PALACKÝ UNIVERSITY   (Czech Republic)

^b DEMOCRITUS UNIVERSITY OF THRACE   (Greece)

^c UNIVERSITÉ PARIS 13   (France)

^d UNIVERSITY OF FREIBURG   (Germany)

^e UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

Author keywords

Association study; Cytokines; Idiopathic pulmonary fibrosis; MUC2; MUC5B; Network analysis; Sequenom MassARRAY; Single nucleotide polymorphism

Indexed keywords

MUCIN 5B;

ARTICLE; CANDIDATE LOCI; CONTROLLED STUDY; CZECH (PEOPLE); DISEASE PREDISPOSITION; EUROPEAN; FIBROSING ALVEOLITIS; FRENCHMAN; GENE FREQUENCY; GENE LOCUS; GENE MUTATION; GENETIC ASSOCIATION; GENETIC MODEL; GERMAN (CITIZEN); GREEK (PEOPLE); HUMAN; MAJOR CLINICAL STUDY; MULTICENTER STUDY; PHENOTYPE; POLYMERASE CHAIN REACTION; PREDICTION; SINGLE NUCLEOTIDE POLYMORPHISM;

EID: 84983335825     PISSN: None     EISSN: 16643224     Source Type: Journal    
DOI: 10.3389/fimmu.2016.00274     Document Type: Article

References (34)

1. Raghu G, Collard HR, Egan JJ, Martinez FJ, Behr J, Brown KK, et al. An official ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management. Am J Respir Crit Care Med (2011) 183:788-824. doi:10.1164/rccm.2009-040GL
2. Mushiroda T, Wattanapokayakit S, Takahashi A, Nukiwa T, Kudoh S, Ogura T, et al. A genome-wide association study identifies an association of a common variant in TERT with susceptibility to idiopathic pulmonary fibrosis. J Med Genet (2008) 45:654-6. doi:10.1136/jmg.2008.057356
3. Fingerlin TE, Murphy E, Zhang W, Peljto AL, Brown KK, Steele MP, et al. Genome-wide association study identifies multiple susceptibility loci for pulmonary fibrosis. Nat Genet (2013) 45:613-20. doi:10.1038/ng.2609
4. Hutyrova B, Pantelidis P, Drabek J, Zurkova M, Kolek V, Lenhart K, et al. Interleukin-1 gene cluster polymorphisms in sarcoidosis and idiopathic pulmonary fibrosis. Am J Respir Crit Care Med (2002) 165:148-51. doi:10.1164/ajrccm.165.2.2106004
5. Ahn MH, Park BL, Lee SH, Park SW, Park JS, Kim DJ, et al. A promoter SNP rs4073T>A in the common allele of the interleukin 8 gene is associated with the development of idiopathic pulmonary fibrosis via the IL-8 protein enhancing mode. Respir Res (2011) 12:73. doi:10.1186/1465-9921-12-73
6. O'Dwyer DN, Armstrong ME, Trujillo G, Cooke G, Keane MP, Fallon PG, et al. The toll-like receptor 3 L412F polymorphism and disease progression in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med (2013) 188:1442-50. doi:10.1164/rccm.201304-0760OC
7. Vasakova M, Sterclova M, Matej R, Olejar T, Kolesar L, Skibova J, et al. IL-4 polymorphisms, HRCT score and lung tissue markers in idiopathic pulmonary fibrosis. Hum Immunol (2013) 74:1346-51. doi:10.1016/j.humimm.2013.07.011
8. Zhang HP, Zou J, Xie P, Gao F, Mu HJ. Association of HLA and cytokine gene polymorphisms with idiopathic pulmonary fibrosis. Kaohsiung J Med Sci (2015) 31:613-20. doi:10.1016/j.kjms.2015.10.007
9. Seibold MA, Wise AL, Speer MC, Steele MP, Brown KK, Loyd JE, et al. A common MUC5B promoter polymorphism and pulmonary fibrosis. N Engl J Med (2011) 364:1503-12. doi:10.1056/NEJMoa1013660
10. Kishore A, Zissel G, Zizkova V, Mueller-Quernheim J, Petrek M. Association of mucin (MUC2, MUC5B) gene variants with idiopathic pulmonary fibrosis (IPF) in a German population: a pilot study using MassARRAY technology. Tissue Antigens (2015) 85:340. doi:10.1111/tan.12557
11. Korthagen NM, van Moorsel CH, Barlo NP, Kazemier KM, Ruven HJ, Grutters JC. Association between variations in cell cycle genes and idiopathic pulmonary fibrosis. PLoS One (2012) 7:e30442. doi:10.1371/journal.pone.0030442
12. Petrek M, Kishore A, Zizkova V. Genetic association study for idiopathic pulmonary fibrosis in a Czech population: results from a pilot study using massarray technology. Am J Respir Crit Care Med (2015) 191:A4382-A. doi:10.1164/ajrccm-conference.2015.191.1_MeetingAbstracts.A4382
13. Uh ST, Kim TH, Shim EY, Jang AS, Park SW, Park JS, et al. Angiotensin-converting enzyme (ACE) gene polymorphisms are associated with idiopathic pulmonary fibrosis. Lung (2013) 191:345-51. doi:10.1007/s00408-013-9469-1
14. Huang Y, Ma SF, Vij R, Oldham JM, Herazo-Maya J, Broderick SM, et al. A functional genomic model for predicting prognosis in idiopathic pulmonary fibrosis. BMC Pulm Med (2015) 15:147. doi:10.1186/s12890-015-0142-8
15. Kishore A, Zizkova V, Kocourkova L, Petrek M. A dataset of 26 candidate gene and pro-inflammatory cytokine variants for association studies in idiopathic pulmonary fibrosis: frequency distribution in normal Czech population. Front Immunol (2015) 6:476. doi:10.3389/fimmu.2015.00476
16. Little J, Higgins JP, Ioannidis JP, Moher D, Gagnon F, von Elm E, et al. Strengthening the reporting of genetic association studies (STREGA): an extension of the STROBE statement. Eur J Epidemiol (2009) 24:37-55. doi:10.1007/s10654-008-9302-y
17. Heath SC, Gut IG, Brennan P, McKay JD, Bencko V, Fabianova E, et al. Investigation of the fine structure of European populations with applications to disease association studies. Eur J Hum Genet (2008) 16:1413-29. doi:10.1038/ejhg.2008.210
18. Lundmark PE, Liljedahl U, Boomsma DI, Mannila H, Martin NG, Palotie A, et al. Evaluation of HapMap data in six populations of European descent. Eur J Hum Genet (2008) 16:1142-50. doi:10.1038/ejhg.2008.77
19. Sanchez-Mazas A, Vidan-Jeras B, Nunes JM, Fischer G, Little AM, Bekmane U, et al. Strategies to work with HLA data in human populations for histocompatibility, clinical transplantation, epidemiology and population genetics: HLA-NET methodological recommendations. Int J Immunogenet (2012) 39:459-72. doi:10.1111/j.1744-313X.2012.01113.x
20. Kubistova Z, Mrazek F, Tudos Z, Kriegova E, Ambruzova Z, Mytilineos J, et al. Distribution of 22 cytokine gene polymorphisms in the healthy Czech population. Int J Immunogenet (2006) 33:261-7. doi:10.1111/j.1744-313X.2006.00609.x
21. American Thoracic Society. Idiopathic pulmonary fibrosis: diagnosis and treatment. International consensus statement. American Thoracic Society (ATS), and the European Respiratory Society (ERS). Am J Respir Crit Care Med (2000) 161:646-64. doi:10.1164/ajrccm.161.2.ats3-00
22. American Thoracic Society, European Respiratory Society. American Thoracic Society/European Respiratory Society International Multidisciplinary Consensus Classification of the Idiopathic Interstitial Pneumonias. This joint statement of the American Thoracic Society (ATS), and the European Respiratory Society (ERS) was adopted by the ATS board of directors, June 2001 and by the ERS Executive Committee, June 2001. Am J Respir Crit Care Med (2002) 165:277-304. doi:10.1164/ajrccm.165.2.ats01
23. Miller SA, Dykes DD, Polesky HF. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res (1988) 16:1215. doi:10.1093/nar/16.3.1215
24. Yang H, Robinson PN, Wang K. Phenolyzer: phenotype-based prioritization of candidate genes for human diseases. Nat Methods (2015) 12:841-3. doi:10.1038/nmeth.3484
25. Seibold MA, Smith RW, Urbanek C, Groshong SD, Cosgrove GP, Brown KK, et al. The idiopathic pulmonary fibrosis honeycomb cyst contains a mucocilary pseudostratified epithelium. PLoS One (2013) 8:e58658. doi:10.1371/journal.pone.0058658
26. van der Vis JJ, Snetselaar R, Kazemier KM, Ten Klooster L, Grutters JC, van Moorsel CH. Effect of Muc5b promoter polymorphism on disease predisposition and survival in idiopathic interstitial pneumonias. Respirology (2016) 21(4):712-7. doi:10.1111/resp.12728
27. Yang IV, Fingerlin TE, Evans CM, Schwarz MI, Schwartz DA. MUC5B and idiopathic pulmonary fibrosis. Ann Am Thorac Soc (2015) 12(Suppl 2):S193-9. doi:10.1513/AnnalsATS.201503-110AW
28. Uhal BD, Kim JK, Li X, Molina-Molina M. Angiotensin-TGF-beta 1 crosstalk in human idiopathic pulmonary fibrosis: autocrine mechanisms in myofibroblasts and macrophages. Curr Pharm Des (2007) 13:1247-56. doi:10.2174/138161207780618885
29. Li X, Molina-Molina M, Abdul-Hafez A, Uhal V, Xaubet A, Uhal BD. Angiotensin converting enzyme-2 is protective but downregulated in human and experimental lung fibrosis. Am J Physiol Lung Cell Mol Physiol (2008) 295:L178-85. doi:10.1152/ajplung.00009.2008
30. Alder JK, Chen JJ, Lancaster L, Danoff S, Su SC, Cogan JD, et al. Short telomeres are a risk factor for idiopathic pulmonary fibrosis. Proc Natl Acad Sci U S A (2008) 105:13051-6. doi:10.1073/pnas.0804280105
31. Wei R, Li C, Zhang M, Jones-Hall YL, Myers JL, Noth I, et al. Association between MUC5B and TERT polymorphisms and different interstitial lung disease phenotypes. Transl Res (2014) 163:494-502. doi:10.1016/j.trsl.2013.12.006
32. Hutchinson J, Fogarty A, Hubbard R, McKeever T. Global incidence and mortality of idiopathic pulmonary fibrosis: a systematic review. Eur Respir J (2015) 46:795-806. doi:10.1183/09031936.00185114
33. Kishore A, Borucka J, Petrkova J, Petrek M. Novel insights into miRNA in lung and heart inflammatory diseases. Mediators Inflamm (2014) 2014:259131. doi:10.1155/2014/259131
34. Rajasekaran S, Rajaguru P, Sudhakar Gandhi PS. MicroRNAs as potential targets for progressive pulmonary fibrosis. Front Pharmacol (2015) 6:254. doi:10.3389/fphar.2015.00254